| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Canada | 5 | |
| #2 | Australia | 4 | |
| #3 | EPO (European Patent Office) | 4 | |
| #4 | United States | 4 | |
| #5 | WIPO (World Intellectual Property Organization) | 4 | |
| #6 | Brazil | 2 | |
| #7 | New Zealand | 2 | |
| #8 | China | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Machines | |
| #3 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Unspecified technologies | |
| #4 | Microorganisms |
| # | Name | Total Patents |
|---|---|---|
| #1 | Gosselin Jean | 22 |
| #2 | Borgeat Pierre | 22 |
| #3 | Tremblay Michel J | 9 |
| #4 | Flamand Louis | 7 |
| #5 | Damaj Bassam | 6 |
| #6 | Fortin Jean-Francois | 4 |
| #7 | Barbeau Benoit | 4 |
| Publication | Filing date | Title |
|---|---|---|
| CA2452008A1 | Ltb4 as vaccine adjuvant | |
| AU7742901A | Method to treat infectious diseases and/or to enhance antimicrobial efficacy of drugs | |
| EP1225891A2 | Use of a bis-peroxovanadium compound for the treatment of immunosupressed patients | |
| CA2244078A1 | Use of leukotriene b4 or its analogues as antiviral and antineoplastic agents | |
| US5789441A | Leukotriene B4 as an antiviral and anti-neoplastic agent | |
| US5900235A | Interleukin-8 as an antiviral and antitumor agent |